Compass Minerals Intl Inc · NYSE:CMP
Compass Minerals Intl — Q4 2025 Earnings Presentation
21 slides from Compass Minerals Intl's earnings presentation, Dec 9, 2025
Slide 1: Fiscal 2025 Fourth-Quarter & Full-Year Business Update
Fiscal 2025 Fourth-Quarter & Full-Year Business Update // Dec. 8, 2025
Slide 2: Forward-Looking Statements and Other Disclaimers
Forward-Looking Statements and Other Disclaimers This presentation may contain forward-looking statements, including, without limitation, statements about the outcome of the North American bid season, including pricing and commitment sizes, the execution of the company's back-to-basics strategy, tax
Slide 3: Fiscal 2025 Fourth-Quarter & Full Year Results
Fiscal 2025 Fourth-Quarter & Full Year Results
Slide 4: Fiscal 2025 Fourth-Quarter and Full-Year Overview
Fiscal 2025 Fourth-Quarter and Full-Year Overview • Net loss for the fourth quarter of 2025 of $7.2 million, improved from a net loss of $48.3 million in comparable prior year period • Total company adjusted EBITDA for the fourth quarter of 2025 of $41.6 million, up from $15.6 million in the prior y
Slide 5: Fourth-Quarter and Fiscal 2025 Consolidated Results
Fourth-Quarter and Fiscal 2025 Consolidated Results 4Q25 Adjusted EBITDA1 (in millions) Consolidated Results 4Q25 FY25 $6.9 $41.6 Revenue (y-o-y) +9% +11% $17.2 Adjusted EBITDA1 (y-o-y) +167% -4% $15.6 $1.9 Adjusted EBITDA1 margin 18.3% 16.0% 4Q24 Salt Plant Corp. & 4Q25 Nutrition Other Historical T
Slide 6: Fourth-Quarter and Fiscal 2025 Salt Results
Fourth-Quarter and Fiscal 2025 Salt Results ($ in millions) 4Q25 4Q24 %Δ FY25 FY24 %Δ Sales Volumes (in thousands of short tons) Revenue $181.6 $162.5 +12.0% $1,022.5 $907.8 +13.0% 8,985 Adj. EBITDA1 $40.0 $38.1 +5.0% $219.2 $228.2 -4.0% 7,462 1,863 1,852 Adj. EBITDA1 margin 22.0% 23.4% -1.4 pts 21.
Slide 7: Fourth-Quarter and Fiscal 2025 Plant Nutrition Results
Fourth-Quarter and Fiscal 2025 Plant Nutrition Results ($ in millions) 4Q25 4Q24 %Δ FY25 FY24 %Δ Revenue $41.8 $42.4 -1.4% $206.3 $181.0 +14.0% Sales Volumes (in thousands of short tons) Adj. EBITDA1 $13.5 $(3.7) nm $34.9 $16.9 +106.5% 326 Adj. EBITDA1 margin 32.3% (8.7)% nm 16.9% 9.3% +7.6pts 273 A
Slide 8: Charting a Prudent Financial Path Forward
Charting a Prudent Financial Path Forward • Successful execution on strategy to harvest Total Net Debt1 cash from working capital through inventory (in millions) rationalization has contributed to a 14% $1,000 Down reduction of net total debt1 year over year as $900 14% $897 of September 30 $800 $77
Slide 9: Outlook & Guidance
Outlook & Guidance
Slide 10: Salt and Plant Nutrition Outlook and Guidance
Salt and Plant Nutrition Outlook and Guidance Salt Plant Nutrition Long-Term Attributes Long-Term Attributes • Resilient, recession-resistant demand profile • Largest producer of SOP in the Western Hemisphere • Difficult to replicate asset base with important logistical advantages • Unique solar eva
Slide 11: Consolidated Guidance Summary
Consolidated Guidance Summary 2026 Adj. EBITDA Range (in millions) Salt $225 $255 Plant Nutrition 31 36 Corporate (56) (51) TOTAL $200 $240 2025 Capital Expenditure Range (in millions) TOTAL $90 $110 Other Consolidated Modeling Information (in millions of dollars unless otherwise noted) 2025 Range I
Slide 12: Appendix
Appendix
Slide 13: Special Items
Special Items Special Items Impacting Three Months Ended Sept. 30,2024 (unaudited, in millions, except per share data) Item Description Segment Line Item Amount Tax Effect1 After Tax EPS Impact Restructuring charges(2) Corporate and Other Other operating expense $(1.4) $--- $(1.4) $(0.04) Impairment
Slide 14: Special Items
Special Items Special Items Impacting the Fiscal Year Ended Sept. 30, 2025 (unaudited, in millions, except per share data) Item Description Segment Line Item Amount Tax Effect1 After Tax EPS Impact Restructuring charges(2) Corporate and Other Other operating expense $4.0 $--- $4.0 $0.09 Restructurin
Slide 15: Reconciliation of Non-GAAP Information
Reconciliation of Non-GAAP Information Reconciliation for Adjusted Operating (Loss) Income (unaudited, in millions) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Operating income (loss) $ 12.0 $ (29.8) $ 25.3 $ (116.8) Restructuring charges1 --- (1.4) 4.3 15.8 Total
Slide 16: Reconciliation of Non-GAAP Information
Reconciliation of Non-GAAP Information Reconciliation for Adjusted Net (Loss) Income (unaudited, in millions) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Net loss $ (7.2) $ (48.3) $ (79.8) $ (206.1) Restructuring charges1 --- (1.4) 4.3 15.8 Total impairment loss2 -
Slide 17: Reconciliation of Non-GAAP Information
Reconciliation of Non-GAAP Information Reconciliation for EBITDA and Adjusted EBITDA (unaudited, in millions) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Net loss $ (7.2) $ (48.3) $ (79.8) $ (206.1) Interest expense 17.3 19.1 68.5 69.5 Income tax expense (benefit)
Slide 18: Salt Segment Performance
Salt Segment Performance Salt Segment Performance (in millions, except for sales volumes and prices per short ton) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Sales $ 181.6 $ 162.5 $ 1,022.5 $ 907.8 Operating income $ 21.5 $ 21.0 $ 145.9 $ 163.6 Operating margin 11
Slide 19: Salt Reconciliation of Non-GAAP Information
Salt Reconciliation of Non-GAAP Information Reconciliation for Salt Segment Adjusted Operating Earnings (unaudited, in millions) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Reported GAAP segment operating income $ 21.5 $ 21.0 $ 145.9 $ 163.6 Restructuring charges1
Slide 20: Plant Nutrition Segment Performance
Plant Nutrition Segment Performance Plant Nutrition Segment Performance (in millions, except for sales volumes and prices per short ton) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Sales $ 41.8 $ 42.4 $ 206.3 $ 181.0 Operating income (loss) $ 6.2 $ (29.7) $ 6.5 $ (
Slide 21: Plant Nutrition Reconciliation of Non-GAAP Information
Plant Nutrition Reconciliation of Non-GAAP Information Reconciliation for Plant Nutrition Segment Adjusted Operating Earnings (unaudited, in millions) Three months ended Twelve months ended Sept. 30, Sept. 30, 2025 2024 2025 2024 Reported GAAP segment operating income (loss) $ 6.2 $ (29.7) $ 6.5 $ (
Compass Minerals Intl — Q4 2025 Earnings Presentation on 6ix